Related Experiment Video
Updated: Jan 26, 2026
12:24
PAR-CliP - A Method to Identify Transcriptome-wide the Binding Sites of RNA Binding Proteins
Published on: July 2, 2010
54.2K
RNA-binding proteins in hematopoiesis and hematological malignancy
Daniel J Hodson1,2, Michael Screen3, Martin Turner3
1Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.
Blood
|April 11, 2019
Summary
RNA-binding proteins (RBPs) are crucial for normal blood cell development and function. Dysregulation of RBPs contributes to blood cancers, offering potential targets for new therapies.
Area of Science:
- Molecular Biology
- Hematology
- Oncology
Background:
- RNA-binding proteins (RBPs) are essential regulators of gene expression, influencing fundamental cellular processes like differentiation and self-renewal.
- RBPs play critical roles in normal hematopoiesis (blood cell formation) and are implicated in hematological malignancies, acting as oncogenes or tumor suppressors.
Purpose of the Study:
- To elucidate the multifaceted roles of RBPs in hematopoiesis and hematological malignancies.
- To highlight the significance of alternative splicing and translation regulation by RBPs in blood cell development and cancer.
Main Methods:
- Review and synthesis of existing literature on RBPs in hematopoiesis and leukemia.
- Analysis of the impact of RBP-mediated alternative splicing and translation control on hematopoietic lineages.
Main Results:
- RBPs are vital for normal blood cell development and function.
- Mutations in RBPs lead to aberrant splicing in leukemias.
- RBPs involved in translation control are key in hematological malignancies and signaling pathways.
Conclusions:
- Understanding RBP functions deepens the mechanistic insight into hematopoiesis.
- RBPs represent promising targets for developing novel biomarkers and therapeutic strategies for blood cancers.
Related Concept Videos
02:36RNA Polymerase II Accessory Proteins
10.8K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.8K
01:20Overview of Hematopoiesis
8.7K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.7K
01:21Hematopoiesis
8.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.9K
01:49Conserved Binding Sites
5.1K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.1K
00:49Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
01:20Factors Affecting Protein-Drug Binding: Protein-Related Factors
538
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
538